Literature DB >> 33375006

CB2 Receptor in Microglia: The Guardian of Self-Control.

Joanna Agnieszka Komorowska-Müller1,2, Anne-Caroline Schmöle1.   

Abstract

Microglia are key to maintaining the homeostasis of the brain. These immune cells of the brain can be our biggest ally in fighting infections, but can worsen pathology or hinder recovery when uncontrolled. Thus, understanding how microglia contribute to neuroinflammatory processes and how their activity can be controlled is of great importance. It is known that activation of endocannabinoid system, and especially the cannabinoid type 2 receptor (CB2R), decreases inflammation. Alongside its non-psychoactive effect, it makes the CB2R receptor a perfect target for treating diseases accompanied by neuroinflammation including neurodegenerative diseases. However, the exact mechanisms by which CB2R regulates microglial activity are not yet understood. Here, we review the current knowledge on the roles of microglial CB2R from in vitro and in vivo studies. We look into CB2R function under physiological and pathological conditions and focus on four different disease models representing chronic and acute inflammation. We highlight open questions and controversies and provide an update on the latest discoveries that were enabled by the development of novel technologies. Also, we discuss the recent findings on the role of microglia CB2R in cognition and its role in neuron-microglia communication.

Entities:  

Keywords:  cannabinoid receptor 2; endocannabinoid system; microglia; neuroinflammation; neuron–microglia-communication

Year:  2020        PMID: 33375006     DOI: 10.3390/ijms22010019

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  12 in total

Review 1.  The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders.

Authors:  Roberto Coccurello; Maria Cristina Marrone; Mauro Maccarrone
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

Review 2.  Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders.

Authors:  Alvaro Morcuende; María Salud García-Gutiérrez; Simone Tambaro; Elena Nieto; Jorge Manzanares; Teresa Femenia
Journal:  Front Psychiatry       Date:  2022-04-15       Impact factor: 5.435

3.  Cannabinoid CB2 Receptors Modulate Microglia Function and Amyloid Dynamics in a Mouse Model of Alzheimer's Disease.

Authors:  Samuel Ruiz de Martín Esteban; Irene Benito-Cuesta; Itziar Terradillos; Ana M Martínez-Relimpio; M Andrea Arnanz; Gonzalo Ruiz-Pérez; Claudia Korn; Catarina Raposo; Roman C Sarott; Matthias V Westphal; Izaskun Elezgarai; Erick M Carreira; Cecilia J Hillard; Uwe Grether; Pedro Grandes; M Teresa Grande; Julián Romero
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

Review 4.  Molecular Pathophysiological Mechanisms in Huntington's Disease.

Authors:  Anamaria Jurcau
Journal:  Biomedicines       Date:  2022-06-17

Review 5.  The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation.

Authors:  Alexander P Young; Eileen M Denovan-Wright
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

6.  Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes.

Authors:  Greg Maguire; Christy Eubanks; George Ayoub
Journal:  Neuronal Signal       Date:  2022-02-16

7.  Inducible Nitric Oxide Synthase Inhibition in the Medial Prefrontal Cortex Attenuates the Anxiogenic-Like Effect of Acute Restraint Stress via CB1 Receptors.

Authors:  Arthur A Coelho; Carla Vila-Verde; Ariandra G Sartim; Daniela L Uliana; Laura A Braga; Francisco S Guimarães; Sabrina F Lisboa
Journal:  Front Psychiatry       Date:  2022-07-14       Impact factor: 5.435

8.  Cannabinoid receptor 2 deficiency enhances isoflurane-induced spatial cognitive impairment in adult mice by affecting neuroinflammation, neurogenesis and neuroplasticity.

Authors:  Chao Li; Jingpu Shi; Jiaguang Sun; Yuanyuan Shi; Huiqun Jia
Journal:  Exp Ther Med       Date:  2021-06-25       Impact factor: 2.447

Review 9.  Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation.

Authors:  Nynke J van den Hoogen; Erika K Harding; Chloé E D Davidson; Tuan Trang
Journal:  Front Neural Circuits       Date:  2022-01-07       Impact factor: 3.492

Review 10.  The Endocannabinoid System in Glial Cells and Their Profitable Interactions to Treat Epilepsy: Evidence from Animal Models.

Authors:  Jon Egaña-Huguet; Edgar Soria-Gómez; Pedro Grandes
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.